NeuroOne Medical Technologies Corporation (Nasdaq: NMTC), a medical technology company focused on surgical solutions for neurological disorders, announced it has been added to the Russell Microcap Index as part of the 2026 Russell indexes reconstitution. The inclusion took effect when the U.S. market opened on June 29, according to a press release.
The Russell Microcap Index consists of the smallest 1,000 securities in the Russell 2000 Index, plus the next 1,000 smallest eligible securities by market capitalization. Membership in the Russell 3000 Index, which includes the 4,000 largest U.S. stocks ranked by total market capitalization, ensures automatic inclusion in the large-cap Russell 1000 Index or small-cap Russell 2000 Index, as well as the appropriate growth and value style indexes.
FTSE Russell, the global index provider, determines membership primarily by objective market-capitalization rankings and style attributes. The Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. According to data as of the end of June 2025, approximately $12.2 trillion in assets are benchmarked against the Russell U.S. indexes.
"We are pleased to be included in the Russell Microcap Index," the company stated, noting that the inclusion may increase its visibility among institutional investors. For more information on the index reconstitution, visit the FTSE Russell website.
NeuroOne markets a minimally invasive and high-definition electrode technology platform with four FDA-cleared product families: Evo Cortical Electrodes, Evo sEEG Electrodes, OneRF Ablation System for the brain, and OneRF Trigeminal Nerve Ablation System. These solutions aim to reduce hospitalizations and surgical procedures, lower costs, and improve patient outcomes by offering both diagnostic and therapeutic functions. The company is also engaged in research and development for drug delivery, basivertebral nerve ablation, and spinal cord stimulation programs.
For additional details, see the original press release on NewMediaWire.
